AI
| Followers | 843 |
| Posts | 122988 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Thursday, September 04, 2008 5:24:43 PM
IDIX Drug Portfolio
What’s changed relative to the prior
version of this chart six months ago?
Three things:
1. IDX184 for HCV has moved from preclinical into phase-1.
2. The HCV protease inhibitors now have names (IDX136, IDX316) and have moved closer to phase-1.
3. The HCV non-nucleoside polymerase inhibitor now has a name (IDX375) and has moved closer to phase-1.
What’s changed relative to the prior
version of this chart six months ago?
Three things:
1. IDX184 for HCV has moved from preclinical into phase-1.
2. The HCV protease inhibitors now have names (IDX136, IDX316) and have moved closer to phase-1.
3. The HCV non-nucleoside polymerase inhibitor now has a name (IDX375) and has moved closer to phase-1.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
